Charlotte Admyre
Chief Tech/Sci/R&D Officer chez INDEX PHARMACEUTICALS HOLDING AB
Profil
Charlotte Admyre is currently the Chief Scientific Officer at InDex Pharmaceuticals Holding AB.
She is also working as a Media Contact at InDex Pharmaceuticals AB.
Dr. Admyre has a graduate and doctorate degree from Karolinska Institutet.
Postes actifs de Charlotte Admyre
| Sociétés | Poste | Début |
|---|---|---|
| INDEX PHARMACEUTICALS HOLDING AB | Chief Tech/Sci/R&D Officer | 02/05/2022 |
InDex Pharmaceuticals AB
 InDex Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology InDex Pharmaceuticals AB is a pharmaceutical development company, which engages in the research, development of technology, and commercialization of scientific discoveries focusing on immunological diseases. It also offers the drug candidate cobitolimod and DiBiCol diagnostic kit. The company was founded was founded on December 14, 2015 and is headquartered in Solna, Sweden. | Public Communications Contact | - |
Formation de Charlotte Admyre
| Karolinska Institutet | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| INDEX PHARMACEUTICALS HOLDING AB | Health Technology |
| Entreprise privées | 1 |
|---|---|
InDex Pharmaceuticals AB
InDex Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology InDex Pharmaceuticals AB is a pharmaceutical development company, which engages in the research, development of technology, and commercialization of scientific discoveries focusing on immunological diseases. It also offers the drug candidate cobitolimod and DiBiCol diagnostic kit. The company was founded was founded on December 14, 2015 and is headquartered in Solna, Sweden. | Health Technology |
